Abstract:Background Atrial fibrillation and flutter (AF/AFl) increase the risk of thromboembolic events by promoting clot formation in the left atrium (LA), which can be visualised using transoesophageal echocardiography (TEE). Current guidelines recommend initiation of oral anticoagulation (OAC) in patients with AF/AFl based solely on CHA2DS2VASc score (congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, history of stroke or thromboembolism, vascular disease, age 65 to 74 years, female sex). Yet, some patients develop left LA thrombus (LAT) and experience thromboembolic events despite OAC. Purpose We sought to develop and externally validate a machine learning model for prediction of presence of LAT based on clinical, laboratory and transthoracic echocardiography (TTE) features. Methods We analyzed data from the multicenter, prospective LATTEE registry (Left Atrial Thrombus on Transesophageal Echocardiography) that included patients from 13 sites who underwent TEE before cardioversion or ablation between November 2018 and March 2021. We used XgBoost model to predict presence of LAT in TEE based on 29 clinical features, 10 biomarkers and 5 TTE measurements. We trained and tested the model internally using 10-fold hold-out cross validation and data from 12 sites (N=2489). We then tested the final model externally using data from the 13th site (that had recruited most patients, N=400). We compared the predictive performance with that of CHA2DS2VASc score using areas under receiver operating curve (AUC) and DeLong test. Results In the training and internal testing cohort the median age was 67 (Inter Quartile Range [IQR] 59, 74), 63% were male, 85% received OAC and LAT was found in 8.4%. Ablation was the indication for TEE in 43%, cardioversion in 57%. In internal, 10-fold hold-out cross validation, the model achieved AUC of 0.755 (95% confidence interval [CI]: 0.722, 0.788) while CHA2DS2VASc performed significantly worse with AUC of 0.638 (95% CI: 0.604, 0.673), P<0.0001 (Figure 1). Left ventricular ejection fraction, rhythm at the time of study (AF/AFl or sinus rhythm) and age received the highest feature importance ranking (Figure 2). In the external testing cohort the median age was 67 (IQR 59, 74), 66% were male, 88% received OAC, ablation was the indication for TEE in 49% of cases and LAT was found in 6.8%. In this external cohort, our model achieved AUC of 0.815 (95% CI: 0.741, 0.889) while CHA2DS2VASc performed significantly worse with AUC of 0.684 (95% CI: 0.583, 0.785), P=0.028. Conclusion Machine learning based on readily available clinical data allows accurate prediction of the presence of LAT in patients with AF/AFl irrespective of OAC treatment. Such score could be used to identify patients who should undergo TEE before ablation or cardioversion. Subsequent studies to clinically evaluate such application of our model as well as how the model can predict future thromboembolic events are warranted. Funding Acknowledgement Type of funding sources: None.

Incidence and predictors of left atrial thrombus in patients with atrial fibrillation under anticoagulation therapy

Determinants of Left Atrial Thrombus or Spontaneous Echo Contrast in Nonvalvular Atrial Fibrillation

New Perspective on the Risk Markers for Left Atrial Thrombosis in Patients with Atrial Fibrillation.

Comparison of transesophageal echocardiography findings after different anticoagulation strategies in patients with atrial fibrillation: a systematic review and meta-analysis

Predicting the presence of left atrial appendage thrombus with clinical features and transthoracic measurements using machine learning

A nomogram for predicting left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients using hemodynamic parameters from transthoracic echocardiography

P1360Association between left atrial appendage dysfunction and thromboembolic risk in nonvalvular atrial fibrillation

Predictors of thrombosis of left atrium and its appendage before catheter ablation or cardioversion in patients with non-valvular atrial fibrillation or atrial flutter

Novel Models for the Prediction of Left Atrial Appendage Thrombus in Patients with Chronic Nonvalvular Atrial Fibrillation

Predictors of left atrial appendage thrombus in atrial fibrillation patients undergoing cardioversion

Machine learning model for predicting left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients based on multimodal echocardiographic parameters

Association Betweenleft Atrial Appendage Function Assessed by Speckle-Tracking Echocardiography and the Presence Ofleft Atrial Appendage Stasis in Patients with Atrial Fibrillation

Left atrial function to identify patients with atrial fibrillation at high risk of stroke: new insights from a large registry

Identifying Left Atrium and Left Atrial Appendage Prone to Thrombus Formation in Patients with Atrial Fibrillation Using Statistical Shape Modeling

Prevalence of left atrial appendage thrombus and spontaneous echo contrast on transesophageal echocardiography in patients scheduled for pulmonary vein isolation

Evaluating the novel parameters for assessing the LAA function and thrombus formation with nonvalvular atrial fibrillation

Left atrial volume index as a predictor for left atrial appendage thrombus in patients with non‐valvular atrial fibrillation receiving appropriate oral anticoagulation therapy: A prospective multi‐center study

Left atrial appendage filling defect in exclusive early-phase scanning of dual-phase cardiac computed tomography: an indicator for elevated thromboembolic risk

Left atrial function for predicting atrial fibrillation: a machine learning approach

The Impact of Left Atrial Morphology on Thrombosis Risk in Atrial Fibrillation

Morphology and location of thrombus and sludge in patients with non-valvular atrial fibrillation